Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

NCT06226805 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: BB-031
DRUG: Placebo

Sponsor

Basking Biosciences, Inc.